J. Paul Davignon

432 total citations
17 papers, 318 citations indexed

About

J. Paul Davignon is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, J. Paul Davignon has authored 17 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Oncology. Recurrent topics in J. Paul Davignon's work include Cannabis and Cannabinoid Research (3 papers), Poisoning and overdose treatments (2 papers) and Safe Handling of Antineoplastic Drugs (2 papers). J. Paul Davignon is often cited by papers focused on Cannabis and Cannabinoid Research (3 papers), Poisoning and overdose treatments (2 papers) and Safe Handling of Antineoplastic Drugs (2 papers). J. Paul Davignon collaborates with scholars based in United States, Netherlands and Malaysia. J. Paul Davignon's co-authors include James C. Cradock, Charles G. Moertel, Stephen E. Jones, Thomas R. Fleming, Joseph Rubin, Robert Koch, Gregory Sarna, Charles W. Young, Violante E. Currie and Larry K. Kvols and has published in prestigious journals such as New England Journal of Medicine, Journal of Chromatography A and International Journal of Pharmaceutics.

In The Last Decade

J. Paul Davignon

15 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Paul Davignon United States	9	68	68	61	48	43	17	318
Hans-Michael Thiede Germany	11	72 1.1×	90 1.3×	43 0.7×	54 1.1×	23 0.5×	20	426
N.M. Al-Gharably Saudi Arabia	9	50 0.7×	36 0.5×	152 2.5×	23 0.5×	50 1.2×	20	394
Stefania Milazzo Australia	13	62 0.9×	101 1.5×	105 1.7×	39 0.8×	58 1.3×	21	537
Melanie Johns Cupp United States	6	51 0.8×	93 1.4×	198 3.2×	76 1.6×	111 2.6×	9	456
Shide Zhang China	12	82 1.2×	26 0.4×	38 0.6×	19 0.4×	31 0.7×	32	390
Padmanabh V. Rataboli India	9	50 0.7×	31 0.5×	53 0.9×	19 0.4×	41 1.0×	18	386
Takeshi Masuyama Japan	13	79 1.2×	25 0.4×	45 0.7×	21 0.4×	43 1.0×	22	394
Hildegard Sourgens Germany	12	45 0.7×	32 0.5×	36 0.6×	42 0.9×	23 0.5×	31	394
A.M. Sponta Italy	3	73 1.1×	25 0.4×	17 0.3×	103 2.1×	29 0.7×	4	332
Edward A. Sasse United States	9	106 1.6×	23 0.3×	17 0.3×	30 0.6×	45 1.0×	17	471

Countries citing papers authored by J. Paul Davignon

Since Specialization

Citations

This map shows the geographic impact of J. Paul Davignon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Paul Davignon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Paul Davignon more than expected).

Fields of papers citing papers by J. Paul Davignon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Paul Davignon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Paul Davignon. The network helps show where J. Paul Davignon may publish in the future.

Co-authorship network of co-authors of J. Paul Davignon

This figure shows the co-authorship network connecting the top 25 collaborators of J. Paul Davignon. A scholar is included among the top collaborators of J. Paul Davignon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Paul Davignon. J. Paul Davignon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Davignon, J. Paul. (1997). 2.C.5 The pleiotropic effects of drugs affecting lipid metabolism. Atherosclerosis. 134(1-2). 103–103. 10 indexed citations

Davignon, J. Paul, et al.. (1988). EORTC/CRC/NCI guidelines for the formulation of investigational cytotoxic drugs. European Journal of Cancer and Clinical Oncology. 24(9). 1535–1538. 13 indexed citations

Davignon, J. Paul, Marianne Xhignesse, & Ghislaine O. Roederer. (1988). Identification of the patient at risk in the physician's office and drug management of dyslipoproteinemia.. PubMed. 4 Suppl A. 36A–47A. 2 indexed citations

O’Dwyer, Peter J., Dale Shoemaker, Hiremagalur N. Jayaram, et al.. (1984). Tiazofurin: A new antitumor agent. Investigational New Drugs. 2(1). 79–84. 30 indexed citations

Shoemaker, Dale, Peter J. O’Dwyer, Silvia Marsoni, et al.. (1983). Spiromustine: a new agent entering clinical trials. Investigational New Drugs. 1(4). 303–308. 13 indexed citations

Poochikian, Guirag, James C. Cradock, & J. Paul Davignon. (1983). Heroin: Stability and formulation approaches. International Journal of Pharmaceutics. 13(2). 219–226. 14 indexed citations

Moertel, Charles G., Thomas R. Fleming, Joseph Rubin, et al.. (1982). A Clinical Trial of Amygdalin (Laetrile) in the Treatment of Human Cancer. New England Journal of Medicine. 306(4). 201–206. 163 indexed citations

Abraham, David, et al.. (1981). Mechanism for National Distribution of Δ⁹‐Tetrahydrocannabinol (NSC‐134454). The Journal of Clinical Pharmacology. 21(S1). 122S–127S. 1 indexed citations

Flora, Karl P., James C. Cradock, & J. Paul Davignon. (1981). Determination of Δ9-tetrahydrocannabinol in pharmaceutical vehicles by high-performance liquid chromatography vehicles by high-performance liquid chromatography. Journal of Chromatography A. 206(1). 117–123. 9 indexed citations

10.

Trissel, Lawrence A., et al.. (1979). Investigational Drug Information. Drug Intelligence & Clinical Pharmacy. 13(6). 340–343. 4 indexed citations

11.

Trissel, Lawrence A., et al.. (1978). Investigational Drug Information. Drug Intelligence & Clinical Pharmacy. 12(7). 404–406. 2 indexed citations

12.

Rahman, Aquilur, James C. Cradock, & J. Paul Davignon. (1978). Dissolution and Absorption of the Antineoplastic Agent Ellipticine. Journal of Pharmaceutical Sciences. 67(5). 611–614. 9 indexed citations

13.

Cradock, James C., et al.. (1977). Intrathecal injections--a review of pharmaceutical factors.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 31(5). 237–47. 8 indexed citations

14.

Davignon, J. Paul, et al.. (1976). Investigational Drug Information. Drug Intelligence & Clinical Pharmacy. 10(1). 48–49. 1 indexed citations

15.

Cradock, James C., J. Paul Davignon, Charles L. Litterst, & Anthony M. Guarino. (1973). An intravenous formulation of Δ9-tetrahydrocannabinol using a non-ionic surfactant. Journal of Pharmacy and Pharmacology. 25(4). 345–345. 33 indexed citations

16.

Davignon, J. Paul, et al.. (1960). Studies on a new hypotensive agent: bretylium tosylate.. PubMed. 82. 872–7. 1 indexed citations

17.

Davignon, J. Paul, et al.. (1960). Guanethidine administration in 28 hypertensive patients.. PubMed. 83. 690–5. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact